Is Wegovy Good For Weight Loss? UK Clinical Evidence

Clinically Proven UK Registered Pharmacy

Is Wegovy Good For Weight Loss? Clinical Evidence

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £79.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Is Wegovy Good For Weight Loss? Clinical Evidence

Is Wegovy good for weight loss UK patients ask frequently, and the clinical evidence is compelling. Wegovy (semaglutide 2.4mg) demonstrated an average 15% body weight reduction in the landmark STEP trials, making it one of the most effective prescription weight loss treatments licensed by the MHRA [1]. At Cured Pharmacy, Wegovy is available from £79.00 following a free online consultation with our UK-registered prescribers.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your body produces after eating [1]. This medication works through three primary mechanisms: it slows gastric emptying so you feel fuller for longer, reduces appetite signals in the brain, and improves blood sugar regulation. Unlike older weight loss medications that target only one pathway, semaglutide's multi-faceted approach addresses the complex biological drivers of obesity.

The 2.4mg dose used in Wegovy is specifically optimised for weight management, higher than the doses used for type 2 diabetes treatment. Clinical pharmacology studies show peak semaglutide concentrations occur 1-3 days after injection, with steady-state levels achieved after 4-5 weeks of consistent weekly dosing [2]. This explains why prescribers gradually increase your dose over 16-20 weeks rather than starting at the full therapeutic level.

Wegovy Clinical Trial Results: The STEP Programme Evidence

The STEP (Semaglutide Treatment Effect in People with obesity) trials represent the gold standard evidence for is Wegovy good for weight loss questions. STEP 1, the largest trial involving 1,961 adults with obesity, showed participants lost an average 14.9% of their initial body weight over 68 weeks compared to 2.4% with placebo [1]. More impressively, 86.4% of Wegovy users achieved at least 5% weight loss, whilst 69.1% lost 10% or more.

STEP 2 specifically examined semaglutide in patients with type 2 diabetes and overweight, demonstrating average weight loss of 9.6% versus 3.4% with placebo over 68 weeks [3]. This trial confirmed Wegovy's effectiveness even in metabolically complex patients. STEP 3 combined semaglutide with intensive behavioural therapy, achieving remarkable 16% average weight reduction [4]. Across all STEP trials, weight loss was accompanied by improvements in waist circumference, blood pressure, cholesterol levels, and inflammatory markers.

Long-Term Weight Maintenance Data

The STEP 4 trial addressed a critical question: what happens when you stop Wegovy? Participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of their lost weight over the following year, whilst those continuing treatment maintained their weight loss [5]. This evidence demonstrates Wegovy works as a long-term weight management medication rather than a short-term fix, similar to how blood pressure medications require ongoing use to maintain therapeutic benefits.

Who Is Wegovy Suitable For in the UK?

MHRA licensing and NICE guidance specify Wegovy is indicated for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [6]. Your UK prescriber will calculate your BMI during consultation and assess whether you meet clinical criteria. Wegovy is not licensed for cosmetic weight loss in individuals at healthy weight ranges.

Certain medical conditions require careful evaluation before starting Wegovy. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2]. Your prescriber will also review your history of pancreatitis, severe gastrointestinal disease, diabetic retinopathy, and current medications. Pregnant or breastfeeding women should not use Wegovy, and effective contraception is recommended during treatment due to limited safety data.

Treatment Active Ingredient Administration Average Weight Loss Starting Price
Wegovy Semaglutide 2.4mg Weekly injection 15% over 68 weeks From £89.00
Saxenda Liraglutide 3mg Daily injection 6-8% over 56 weeks From £68.00
Orlistat Orlistat 120mg Three times daily oral 3-5% over 12 months From £24.00
Mysimba Naltrexone/Bupropion Twice daily oral 5-6% over 56 weeks From £49.00

Wegovy Dosing Schedule and What to Expect

Wegovy treatment follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss. You begin with 0.25mg weekly for four weeks, then increase monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg [2]. This gradual titration allows your body to adapt to semaglutide's effects on gastric emptying and appetite.

Most patients begin noticing appetite reduction within the first 2-4 weeks, even at lower starter doses. Measurable weight loss typically becomes evident by week 8-12, with progressive reduction continuing through the first year of treatment. Clinical trial data shows the majority of weight loss occurs in the first 60 weeks, after which weight tends to stabilise at a new lower baseline [1]. Your UK prescriber will monitor your progress at regular intervals and may adjust your treatment plan if you experience tolerability issues or inadequate response.

Injection Technique and Storage

Wegovy pens are pre-filled single-use injectors administered subcutaneously once weekly, on the same day each week. You can inject into your abdomen, thigh, or upper arm, rotating injection sites to prevent lipodystrophy. The pens must be stored in a refrigerator between 2-8°C before first use, though they can remain at room temperature up to 30°C for up to 28 days if needed for travel [2]. Each pen contains four doses at the appropriate strength for your current phase of treatment.

Common Side Effects and How to Manage Them

Gastrointestinal effects are the most frequently reported side effects with Wegovy, occurring in approximately 44% of trial participants [1]. Nausea, typically mild to moderate, is most common during dose escalation phases and usually diminishes within 4-8 weeks as your body adapts. Other digestive effects include diarrhoea, constipation, vomiting, and abdominal discomfort. These symptoms are generally transient and can be managed through dietary modifications such as eating smaller portions, avoiding high-fat meals, and staying well-hydrated.

Serious adverse events are rare but require awareness. Acute pancreatitis occurred in 0.2% of semaglutide users versus 0.1% with placebo in pooled trial data [3]. Warning signs include severe persistent abdominal pain radiating to the back, often accompanied by vomiting. Gallbladder problems, including cholelithiasis, occurred more frequently with rapid weight loss. Hypoglycaemia risk is low in non-diabetic patients but may occur if you're taking other glucose-lowering medications. Your prescriber will provide detailed safety information and advise when to seek medical attention.

Is Wegovy Good for Weight Loss Compared to Alternatives?

When evaluating is Wegovy good for weight loss against other UK-licensed options, head-to-head trial data provides valuable context. Semaglutide 2.4mg demonstrated superior weight loss compared to liraglutide 3mg (Saxenda), with average reductions of 15.8% versus 6.4% respectively in the STEP 8 trial [7]. Wegovy users were significantly more likely to achieve 10%, 15%, and 20% weight loss thresholds. However, newer dual GIP/GLP-1 receptor agonists have shown even greater efficacy in recent trials.

Orlistat, the only non-prescription weight loss medication available in UK pharmacies, works through an entirely different mechanism by blocking fat absorption in the intestines. Whilst orlistat is more accessible and lower cost, clinical trials show average weight loss of just 3-5% compared to Wegovy's 15% [8]. The choice between treatments depends on your clinical profile, tolerance for injections versus oral medication, budget considerations, and weight loss goals. Your UK prescriber at Cured Pharmacy will discuss which option aligns best with your individual circumstances, all subject to clinical assessment and approval.

Cost Considerations and Value

Wegovy represents a significant investment in your health, with treatment costs varying across UK pharmacy providers. At Cured Pharmacy, transparent upfront pricing from £79.00 per month ensures you understand costs before completing your clinical consultation. This competitive pricing includes your medication, prescriber assessment, and discreet delivery. Many patients find the clinical benefits—substantial weight loss, improved metabolic markers, and reduced obesity-related health risks—justify the ongoing cost when compared to potential long-term healthcare expenses associated with untreated obesity.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799
  3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
  4. Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831
  5. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
  6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. Retrieved from https://www.nice.org.uk/guidance/ta875
  7. Rubino, D. M., Greenway, F. L., Khalid, U., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619
  8. Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Wegovy good for weight loss if I only need to lose 1-2 stone?
Wegovy is licensed for patients with BMI ≥30 or ≥27 with weight-related health conditions, not for cosmetic weight loss. Your UK prescriber will assess whether you meet clinical criteria during your consultation, as the medication is most appropriate for significant weight management needs rather than modest cosmetic goals.
How quickly does Wegovy work for weight loss?
Most patients notice reduced appetite within 2-4 weeks of starting Wegovy, with measurable weight loss typically evident by weeks 8-12. Clinical trials show progressive weight reduction continuing through the first 60 weeks, with average peak weight loss of 15% achieved around 68 weeks.
Can I get Wegovy on the NHS in the UK?
NHS England has restricted Wegovy availability due to supply constraints and budget limitations, with access typically limited to specialist weight management services in some regions. Private prescription through UK-registered pharmacies like Cured Pharmacy offers an alternative route, subject to prescriber assessment and approval.
Do I need to diet and exercise whilst taking Wegovy?
Yes, Wegovy is licensed as an adjunct to reduced-calorie diet and increased physical activity, not as monotherapy. Clinical trials included lifestyle intervention alongside medication, and NICE guidance recommends combining Wegovy with behavioural support for optimal outcomes.
What happens if I miss a Wegovy injection?
If you miss a dose and it's within 5 days of your scheduled day, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and resume your normal weekly schedule. Missing multiple doses may require restarting the dose escalation protocol under prescriber guidance.
Is Wegovy good for weight loss long-term or will I regain weight?
STEP 4 trial data shows patients who discontinued Wegovy regained approximately two-thirds of lost weight within a year, whilst those continuing treatment maintained their reduction. This evidence suggests Wegovy functions as a long-term weight management medication requiring ongoing use, similar to treatments for other chronic conditions.
Can I use Wegovy if I have type 2 diabetes?
Yes, semaglutide is safe and effective for weight loss in people with type 2 diabetes, as demonstrated in the STEP 2 trial showing 9.6% average weight reduction. Your prescriber will review your current diabetes medications, as dose adjustments may be needed to prevent hypoglycaemia when combining treatments.
How does Cured Pharmacy ensure Wegovy is genuine UK-licensed medication?
Cured Pharmacy (GPhC registration 9012511) sources all medicines exclusively through UK-licensed wholesalers in accordance with MHRA regulations. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing to ensure every Wegovy pen is genuine, properly stored, and within expiry date before dispatch.